Nisa Investment Advisors
ZNTL icon

Nisa Investment Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Nisa Investment Advisors’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88K Hold
387
– – ﹤0.01% 2762
2026
Q1 		$906 Hold
387
– – ﹤0.01% 2765
2025
Q4 		$522 Hold
387
– – ﹤0.01% 2811
2025
Q3 		$584 Hold
387
– – ﹤0.01% 2830
2025
Q2 		$449 Buy
387
+60
+18% +$79 ﹤0.01% 2889
2025
Q1 		$520 Sell
327
-543
-62% -$1.17K ﹤0.01% 2785
2024
Q4 		$2.64K Buy
870
+749
+619% +$2.46K ﹤0.01% 2408
2024
Q3 		$445 Sell
121
-4,696
-97% -$17.1K ﹤0.01% 2739
2024
Q2 		$19.7K Buy
4,817
+4,131
+602% +$46.1K ﹤0.01% 1950
2024
Q1 		$10.8K Buy
686
+121
+21% +$1.66K ﹤0.01% 2023
2023
Q4 		$8.56K Hold
565
– – ﹤0.01% 2068
2023
Q3 		$11.3K Sell
565
-1,020
-64% -$25.9K ﹤0.01% 2147
2023
Q2 		$44.7K Buy
1,585
+340
+27% +$8.16K ﹤0.01% 1786
2023
Q1 		$21K Buy
1,245
+30
+2% +$608 ﹤0.01% 2002
2022
Q4 		$24K Sell
1,215
-23
-2% -$495 ﹤0.01% 2015
2022
Q3 		$31K Buy
1,238
+38
+3% +$1.04K ﹤0.01% 1919
2022
Q2 		$34K Buy
1,200
+20
+2% +$530 ﹤0.01% 1873
2022
Q1 		$54K Sell
1,180
-180
-13% -$9.71K ﹤0.01% 1819
2021
Q4 		$78K Sell
1,360
-320
-19% -$24.8K ﹤0.01% 1603
2021
Q3 		$112K Hold
1,680
– – ﹤0.01% 1651
2021
Q2 		$89K Buy
+1,680
New +$90K ﹤0.01% 1750

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Nisa Investment Advisors's ZNTL Position: Q2 2026 in Review

Nisa Investment Advisors held its Zentalis Pharmaceuticals (ZNTL) position steady in Q2 2026 at 387 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Nisa Investment Advisors first reported a position in ZNTL in Q2 2021 and has held it in 21 quarters since. The position peaked at $112K in Q3 2021. 113 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Nisa Investment Advisors held 387 shares of Zentalis Pharmaceuticals worth $1.88K as of Q2 2026.
  • Nisa Investment Advisors left its Zentalis Pharmaceuticals share count unchanged in Q2 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2762 holding.
  • Nisa Investment Advisors first reported a position in Zentalis Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Nisa Investment Advisors's Zentalis Pharmaceuticals position peaked at $112K in Q3 2021.
  • 113 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.